Keyphrases
Irinotecan
100%
Colorectal Cancer Patients
100%
ABCG2
100%
ABCG2 Gene
40%
Protein Expression
30%
MRNA Expression
30%
Cairo
20%
Metastatic Colorectal Cancer (mCRC)
20%
Immunoreactivity
10%
Subcellular Localization
10%
Scoring Protocol
10%
Result Interpretation
10%
Gene Expression
10%
Tumor Tissue
10%
Primary Response
10%
Topoisomerase Inhibitors
10%
Primary Tumor
10%
Biological Role
10%
Discrepant Results
10%
Drug Use
10%
Resistance Development
10%
Xenobiotics
10%
Immunohistochemistry
10%
Breast Cancer Resistance Protein
10%
ATP-binding Cassette Transporter A1 (ABCA1)
10%
Lack of Efficacy
10%
Clinical Significance
10%
Medicine and Dentistry
Breast Cancer Resistance Protein
100%
Colorectal Carcinoma
100%
Irinotecan
100%
Protein Expression
21%
Messenger RNA
21%
Gene Expression
7%
Neoplasm
7%
Topoisomerase
7%
Xenobiotics
7%
ABC Transporter
7%
Antiinfective Agent
7%
Primary Tumor
7%
Metastatic Colorectal Cancer
7%
Clinical Significance
7%
Immunoreactivity
7%
Immunohistochemistry
7%
Pharmacology, Toxicology and Pharmaceutical Science
ABCG2
100%
Irinotecan
100%
Colorectal Carcinoma
100%
Messenger RNA
21%
ABC Transporter
7%
DNA Topoisomerase
7%
Neoplasm
7%
Antiinfective Agent
7%
Metastatic Colorectal Cancer
7%
Primary Tumor
7%
Biochemistry, Genetics and Molecular Biology
ABCG2
100%
Protein Expression
21%
Messenger RNA
21%
Subcellular Localization
7%
DNA Topoisomerase
7%
Gene Expression
7%
ABC Transporter
7%
Immunoreactivity
7%
ATP-binding Cassette Transporter
7%
Topoisomerase
7%